Trump Media & Technology (DJTWW) had the highest return between December 27, 2023 and January 30, 2024 by a mid-cap US stock, returning 137.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Trump Media & Technology (DJTWW) | 12/27/2023 - 1/30/2024 | 137.35% |
Dave (DAVE) | 12/27/2023 - 1/30/2024 | 114.48% |
Trump Media & Technology (DJT) | 12/27/2023 - 1/30/2024 | 107.35% |
Sezzle Inc Common Stock (SEZL) | 12/27/2023 - 1/30/2024 | 101.24% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 12/27/2023 - 1/30/2024 | 77.4% |
Oscar Health (OSCR) | 12/27/2023 - 1/30/2024 | 37.74% |
Tarsus Pharmaceuticals (TARS) | 12/27/2023 - 1/30/2024 | 36.36% |
Alvotech (ALVO) | 12/27/2023 - 1/30/2024 | 34.85% |
Appfolio (APPF) | 12/27/2023 - 1/30/2024 | 27.93% |
Advantage Solutions (ADVWW) | 12/27/2023 - 1/30/2024 | 26.83% |
Kemper (KMPR) | 12/27/2023 - 1/30/2024 | 26.32% |
CG Oncology, Inc Common stock (CGON) | 12/27/2023 - 1/30/2024 | 25.86% |
Avidity Biosciences (RNA) | 12/27/2023 - 1/30/2024 | 25% |
GeneDx (WGS) | 12/27/2023 - 1/30/2024 | 24.42% |
Merus (MRUS) | 12/27/2023 - 1/30/2024 | 24.24% |
Viking Therapeutics (VKTX) | 12/27/2023 - 1/30/2024 | 23.36% |
Rumble (RUM) | 12/27/2023 - 1/30/2024 | 23.03% |
Ideaya Biosciences (IDYA) | 12/27/2023 - 1/30/2024 | 22.75% |
ADMA Biologics (ADMA) | 12/27/2023 - 1/30/2024 | 22.71% |
Sanmina (SANM) | 12/27/2023 - 1/30/2024 | 22.68% |
Turkcell Iletisim Hizmetleri AS (TKC) | 12/27/2023 - 1/30/2024 | 21.17% |
Kymera Therapeutics (KYMR) | 12/27/2023 - 1/30/2024 | 21.12% |
Grupo Financiero Galicia SA ADR (GGAL) | 12/27/2023 - 1/30/2024 | 20.96% |
Torm PLC Class A (TRMD) | 12/27/2023 - 1/30/2024 | 20.03% |
Organon (OGN) | 12/27/2023 - 1/30/2024 | 18.67% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
